Navigation Links
Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
Date:11/9/2012

p>During Mr. Klein's employment with Omeros, he used Omeros' Whistleblower Policy procedures to report to the chairman of Omeros' audit committee that the Company had submitted reimbursement claims to the NIH in connection with the grant for work that Omeros had not performed. Omeros' audit committee, with independent outside counsel, thoroughly investigated Mr. Klein's allegations and the Company's NIH grant and claims procedures. The facts gathered by this investigation demonstrate that Omeros underbilled – not overbilled – the NIH in connection with the grant.  In May 2009, Omeros voluntarily reported to the NIH's Office of Compliance the Company's handling of Mr. Klein's whistleblow allegation and the nature of its research under the grant.

Mr. Klein subsequently presented his claims to the U.S. government, which declined to intervene in his case following its investigation of those claims. The written evidence shows that the NIH officials who reviewed Omeros' voluntary report acknowledged in 2009 that the Company had satisfactorily addressed the matter. An NIH scientist charged with managing the grant also testified that the research performed by Omeros represented a very valuable scientific advancement.  In addition, the same NIH institute that awarded the grant that was the subject of Mr. Klein's allegations recently awarded Omeros a new grant in support of the Company's research.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-te
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- Registration is officially open for MEDTEC China South 2015, ... Shenzhen Convention & Exhibition Center. The Shenzhen ... the MEDTEC China family of events. MEDTEC China South, an ... serve the South China market through ... region for China,s medical device industry. ...
(Date:3/3/2015)... 2015  RedHill Biopharma Ltd. (NASDAQ/TASE: RDHL) ... company primarily focused on late clinical-stage, proprietary, ... including gastrointestinal cancers, today announced that ... will be presenting at VirtualInvestorConferences.com, a live ... 5, 2015, at 10:00 am EST. ...
(Date:3/3/2015)... , March 3, 2015 - ... 26 June 2015, SNIEC, Shanghai, China ... 10th P-MEC China, will be held at Shanghai New International ... P-MEC China originated from CPhI Worldwide and was introduced to ... important bridge between Chinese pharmaceutical companies and global pharmaceutical industry ...
Breaking Medicine Technology:Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 415th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3
... board of directors of Eli Lilly and Company (NYSE: LLY ... $0.49 a share on outstanding common stock. This is the same dividend ... the total annual dividend for 2011 to $1.96 per share. ... the close of business on November 15, 2011. About ...
... Verisk Health ... Solutions suite to include greater predictive power and reporting ... International Classification of Diseases, Tenth Revision, Clinical Modification ... models that predict emergency department (ED) utilization and measure practice ...
Cached Medicine Technology:Verisk Health's DxCG Risk Solutions Technology Ready to Support Industry Adoption of ICD-10-CM 2
(Date:3/3/2015)... The number of couples experiencing infertility in ... This increases to 50% by the time a woman ... AA, et al. Estimating the prevalence of infertility in ... a reproductive endocrinologist and co-director at Olive Fertility Centre, ... director and founder of Acubalance Wellness Centre will be ...
(Date:3/3/2015)... The North America application delivery ... $1,224.6 million to $1,694.6 million, at a ... , Browse through the TOC of North ... analysis of industry trends and segments, with ... http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , An application delivery ...
(Date:3/3/2015)... 2015 Splashtop Inc. , the ... is now available for Epson® MoverioTM BT-200 smart glasses. ... Moverio Apps Market , iPod, iPhone, and iPad users ... the Epson Moverio smart glasses using Mirroring360, enhancing the ... , The Epson smart glasses have an advanced binocular ...
(Date:3/3/2015)... 2015 OncLive® and Indiana University ... forces to share news about the center’s research ... is part of OncLive’s Strategic Alliance Partnership initiative. ... and marketing teams will partner with the IU ... center, to highlight accomplishments. They include the center’s ...
(Date:3/3/2015)... 03, 2015 Celestix Networks, the ... today announced the global availability of Celestix Cloud ... the world’s most deployed platform for DirectAccess and ... R2. This new release enables organizations to manage ... from a single HTML 5 web interface called ...
Breaking Medicine News(10 mins):Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... 1, 2008 -- 11 a.m. news event -- Hall of ... DC 20001 , , WASHINGTON, ... coming together to outline the current fiscal situation states are ... a recovery package that will spur job growth, support infrastructure ...
... 1 An independent study at the,University of Cumbria found that ... same time as exercising. The games reduce the boredom of,exercise. , ... 12 were asked to use exercise equipment,combined with video games provided ... The children could play their games only while they maintained ...
... Calif., Dec. 1 Transcept Pharmaceuticals,Inc., a privately-held specialty ... Chief Executive Officer, is scheduled to,participate at the RBC ... a panel entitled "Delivering Novel Drug Solutions: The Future ... place on Thursday, December,11, 2008 at 1:30 PM Eastern ...
... Ohio and TAMPA, Fla., Dec. 1 Cardinal,Health and ... agreement to offer surgical kits that include disposable health,care ... from SRI,Surgical. , ... SRI,Surgical,s complete line of more than 400 disposable surgical ...
... can prevent spread of infection , , MONDAY, Dec. 1 (HealthDay ... and older for HIV, says a new practice guideline released ... the virus that causes AIDS. , In the United ... 20,000 new infections are caused each year by people who ...
... Acuo Technologies(R), developers,of high-performance software for intelligent ... announced the contracting with Rush,University Medical ... neutral archiving,solution which becomes the basis of the ... is based on the Acuo Technologies DICOM,Services Grid(TM) ...
Cached Medicine News:Health News:Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect 2Health News:Children Tell Researchers: We'll Get Fit if It's Fun 2Health News:Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel 2Health News:Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits 2Health News:Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits 3Health News:Guideline Urges HIV Tests for All Patients 13 and Older 2Health News:Acuo Technologies Announces Vendor Neutral Archiving Contract With Rush University Medical Center 2Health News:Acuo Technologies Announces Vendor Neutral Archiving Contract With Rush University Medical Center 3
... ARRAY® Multifocal IOL is a foldable silicone ... PMMA haptics and is designed to be ... The ARRAY® Multifocal IOL is the first ... first to offer patients a full range ...
... 2% Hydroxypropyl Methylcellulose solution that is especially ... volume, small incision surgery. The low molecular ... removal with minimal risk of elevated intraocular ... unobstructed view of the surgical field throughout ...
... The visco-elastic ENDOGEL is a sterile, ... hyaluronate. ENDOGEL is supplied in a ... a Luer-Lock fitting, delivering 0,85 ml. ... polysaccharide composed of repetitive chains of ...
... ophthalmic viscosurgical device ... patented HPMC viscoelastic ... performance, economy and ... properties and handling ...
Medicine Products: